Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Amortizatization of Intangibles: 2010-2022

Historic Amortizatization of Intangibles for EyePoint Pharmaceuticals (EYPT) over the last 13 years, with Dec 2022 value amounting to $2.0 million.

  • EyePoint Pharmaceuticals' Amortizatization of Intangibles rose 6.84% to $656,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $2.5 million, marking a year-over-year increase of 23.33%. This contributed to the annual value of $2.0 million for FY2022, which is 18.00% down from last year.
  • EyePoint Pharmaceuticals' Amortizatization of Intangibles amounted to $2.0 million in FY2022, which was down 18.00% from $2.5 million recorded in FY2021.
  • EyePoint Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $2.5 million during FY2019, with a 5-year trough of $981,000 in FY2018.
  • In the last 3 years, EyePoint Pharmaceuticals' Amortizatization of Intangibles had a median value of $2.5 million in 2021 and averaged $2.4 million.
  • As far as peak fluctuations go, EyePoint Pharmaceuticals' Amortizatization of Intangibles skyrocketed by 35.50% in 2018, and later fell by 18.00% in 2022.
  • Yearly analysis of 5 years shows EyePoint Pharmaceuticals' Amortizatization of Intangibles stood at $981,000 in 2018, then reached $2.5 million in 2019, then remained steady at $2.5 million in 2020, then remained steady at $2.5 million in 2021, then dropped by 18.00% to $2.0 million in 2022.